
Shield Therapeutics PLC (QB) (SHIEF)
USOTC
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | USD (US$) | |
Return on Assets (%) | -54.362 | -40.241 | -4.05 | -22.042 | -7.64 | -51.152 | -123.891 | -88.29 |
Return on Equity (%) | -100.938 | -43.722 | -4.39 | -24.251 | -8.427 | -55.457 | -178.464 | -308.597 |
Return on Invested Capital (%) | -67.643 | -38.206 | 1.393 | -17.437 | -1.115 | -50.707 | -103.23 | -134.917 |
Operating Margin (%) | -5127.961 | -3293.093 | -43.001 | -1260.64 | -18.148 | -1310.007 | -888.598 | -239.633 |
Net Profit Margin (%) | -4939.474 | -3075.039 | -15.083 | -1223.922 | -25.32 | -1295.458 | -905.419 | -254.436 |
Book Value Per Share | 0.281 | 0.097 | 0.081 | 0.019 | 0.026 | 0.064 | -0.03 | -0.002 |
Earnings Per Share | -0.218 | -0.168 | -0.015 | -0.075 | -0.022 | -0.091 | -0.192 | -0.043 |
Cash Per Share | 0.304 | 0.114 | 0.084 | 0.035 | 0.025 | 0.056 | 0.013 | 0.018 |
Working Capital Per Share | 0.281 | 0.096 | 0.08 | 0.019 | 0.025 | 0.063 | -0.003 | 0.022 |
Operating Profit Per Share | 0.004 | 0.004 | 0.099 | 0.002 | 0.077 | 0.003 | 0.013 | 0.011 |
EBIT Per Share | -0.226 | -0.18 | -0.044 | -0.077 | -0.016 | -0.092 | -0.19 | -0.041 |
EBITDA Per Share | -0.226 | -0.18 | -0.044 | -0.077 | -0.016 | -0.092 | -0.19 | -0.041 |
Free Cash Flow Per Share | -0.2 | -0.16 | -0.01 | -0.086 | -0.045 | -0.092 | -0.194 | -0.04 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 69M | 116,43M | 116,43M | 117,19M | 117,62M | 215,89M | 259,39M | 782,06M |
Capitalisation boursière | 35,42M |
Ratio cours/bénéfice | -0,95 |
Ratio prix/ventes | 2,42 |
Ratio prix/liquidités | 2,28 |
Ratio prix/valeur comptable | 2,11 |
Rendement de dividende | - |
Actions en circulation | 1,04B |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | 23,64% |
Plus haut sur 52 semaines | 0,0614 |
Plus bas sur 52 semaines | 0,0135 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales